SUBSCRIBE
SUBSCRIBE
News   Policy

Cell Therapeutics, Inc. Focuses on Pixantrone Application in Europe, U.S. Trial and Expanded Access Program; Cuts Burn Rate

April 28, 2010 | 
1 min read
SEATTLE, April 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (Nasdaq and MTA: CTIC) today reported recent accomplishments and financial results for the first quarter ended March 31, 2010.
Regulatory
MORE ON THIS TOPIC
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Created with Canva Dreamlab †
FDA
Makary, Prasad Under Fire as FDA Turmoil Reaches President Trump
February 20, 2026
 · 
6 min read
 · 
Heather McKenzie
The white plane flies against the blue sky, leaving a white trail. Vector illustration
Vaccines
ACIP Meeting Delayed as Turbulence Rocks CDC, US Vaccine Policy
February 20, 2026
 · 
2 min read
 · 
Tristan Manalac
Man hand with magnifying glass. Yellow ray coming from loupe. Conducting check, information search and analysis concept. Spy, accountant, auditor job in abstract style. High quality photo
Regulatory
FDA’s Top Drug Regulator To Probe Safety of Antidepressants, RSV Antibodies
February 20, 2026
 · 
2 min read
 · 
Tristan Manalac